Replies to post #333341 on Anavex Life Sciences Corp (AVXL)

[Doc328]

“I’ll take no further interest or concerns with PRE-084. In regard to the Anavex drugs and the treatment of CNS diseases, it’s irrelevant.”

Exactly.

Why even try and go down that rabbit hole when it ends up pointless. It is not an Anavex drug so trying to understand why this or why that only distracts from the truly impossible.

Missling / Anavex disagree with you. He has repeatedly touted Anavex's potential by comparing to PRE-084 model results.

Beneficial effect of the sigma(1) receptor agonist PRE-084 against the spatial learning deficits in aged rats

PRE-084, a sigma selective PCP derivative, attenuates MK-801-induced impairment of learning in mice.

Anavex Life Sciences Reports New Publication in Medical Journal Elucidating the Mechanism of ANAVEX®2-73 (blarcamesine) and ANAVEX®3-71 (AF710B) related to the Treatment of Alzheimer's Disease

Anavex Life Sciences Reports Publication of New Data that Show ANAVEX®2-73 Induces Cellular Recycling Process Linked to the Prevention and Treatment of Age-Associated Diseases